Heart Defects, Congenital

3 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.

Broader: Cardiovascular Diseases, Heart Diseases

Narrower: Ductus Arteriosus, Patent 2

Treatments and conditions

Heart Defects, Congenital
Treatment and conditionWhere it standsTrials
Empagliflozin for heart defects, congenitalPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
Ibuprofen for ductus arteriosus, patentPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Transcatheter PDA Coil for ductus arteriosus, patentTrial registered, as of 19 Nov 2026 (not yet checked by a person)1

Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.